Annual CFI
-$719.60 M
+$91.90 M+11.32%
31 December 2023
Summary:
United Therapeutics annual cash flow from investing activities is currently -$719.60 million, with the most recent change of +$91.90 million (+11.32%) on 31 December 2023. During the last 3 years, it has risen by +$18.90 million (+2.56%). UTHR annual CFI is now -242.89% below its all-time high of $503.60 million, reached on 31 December 2015.UTHR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$114.90 M
-$34.90 M-43.63%
30 September 2024
Summary:
United Therapeutics quarterly cash flow from investing activities is currently -$114.90 million, with the most recent change of -$34.90 million (-43.63%) on 30 September 2024. Over the past year, it has increased by +$198.50 million (+63.34%). UTHR quarterly CFI is now -115.63% below its all-time high of $735.30 million, reached on 31 March 2024.UTHR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$582.50 M
+$198.50 M+51.69%
30 September 2024
Summary:
United Therapeutics TTM cash flow from investing activities is currently $582.50 million, with the most recent change of +$198.50 million (+51.69%) on 30 September 2024. Over the past year, it has increased by +$1.53 billion (+161.25%). UTHR TTM CFI is now at all-time high.UTHR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.3% | +63.3% | +161.3% |
| 3 y3 years | +2.6% | +51.3% | +264.1% |
| 5 y5 years | +12.3% | +61.5% | +222.9% |
UTHR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -47.8% | +11.3% | -115.6% | +68.0% | at high | +160.7% |
| 5 y | 5 years | -114.5% | +12.3% | -115.6% | +69.4% | at high | +160.7% |
| alltime | all time | -242.9% | +13.9% | -115.6% | +69.4% | at high | +156.7% |
United Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$114.90 M(+43.6%) | $582.50 M(+51.7%) |
| June 2024 | - | -$80.00 M(-110.9%) | $384.00 M(+62.2%) |
| Mar 2024 | - | $735.30 M(+1646.6%) | $236.80 M(-132.9%) |
| Dec 2023 | -$719.60 M(-11.3%) | $42.10 M(-113.4%) | -$719.60 M(-24.3%) |
| Sept 2023 | - | -$313.40 M(+37.9%) | -$951.00 M(+30.0%) |
| June 2023 | - | -$227.20 M(+2.8%) | -$731.60 M(+8.6%) |
| Mar 2023 | - | -$221.10 M(+16.8%) | -$673.40 M(-17.0%) |
| Dec 2022 | -$811.50 M(+66.7%) | -$189.30 M(+101.4%) | -$811.50 M(-0.8%) |
| Sept 2022 | - | -$94.00 M(-44.4%) | -$818.00 M(-14.8%) |
| June 2022 | - | -$169.00 M(-53.0%) | -$959.90 M(+14.3%) |
| Mar 2022 | - | -$359.20 M(+83.5%) | -$839.80 M(+72.5%) |
| Dec 2021 | -$486.90 M(-34.1%) | -$195.80 M(-17.0%) | -$486.90 M(+37.2%) |
| Sept 2021 | - | -$235.90 M(+382.4%) | -$354.90 M(-9.2%) |
| June 2021 | - | -$48.90 M(+676.2%) | -$390.70 M(-45.5%) |
| Mar 2021 | - | -$6.30 M(-90.1%) | -$717.20 M(-2.9%) |
| Dec 2020 | -$738.50 M(+120.2%) | -$63.80 M(-76.5%) | -$738.50 M(+21.4%) |
| Sept 2020 | - | -$271.70 M(-27.6%) | -$608.50 M(-4.2%) |
| June 2020 | - | -$375.40 M(+1260.1%) | -$635.50 M(+109.9%) |
| Mar 2020 | - | -$27.60 M(-141.7%) | -$302.70 M(-9.7%) |
| Dec 2019 | -$335.40 M(-59.1%) | $66.20 M(-122.2%) | -$335.40 M(-29.2%) |
| Sept 2019 | - | -$298.70 M(+601.2%) | -$473.80 M(-6.2%) |
| June 2019 | - | -$42.60 M(-29.4%) | -$505.00 M(-38.6%) |
| Mar 2019 | - | -$60.30 M(-16.5%) | -$822.20 M(+0.2%) |
| Dec 2018 | -$820.60 M(-1.8%) | -$72.20 M(-78.1%) | -$820.60 M(-20.1%) |
| Sept 2018 | - | -$329.90 M(-8.3%) | -$1.03 B(+14.5%) |
| June 2018 | - | -$359.80 M(+512.9%) | -$897.10 M(+23.1%) |
| Mar 2018 | - | -$58.70 M(-78.9%) | -$728.70 M(-12.8%) |
| Dec 2017 | -$835.60 M(-1830.0%) | -$278.40 M(+39.1%) | -$835.60 M(+52.3%) |
| Sept 2017 | - | -$200.20 M(+4.6%) | -$548.70 M(+67.1%) |
| June 2017 | - | -$191.40 M(+15.6%) | -$328.40 M(+154.0%) |
| Mar 2017 | - | -$165.60 M(-2048.2%) | -$129.30 M(-367.7%) |
| Dec 2016 | $48.30 M(-90.4%) | $8.50 M(-57.7%) | $48.30 M(-49.8%) |
| Sept 2016 | - | $20.10 M(+161.0%) | $96.30 M(-77.3%) |
| June 2016 | - | $7.70 M(-35.8%) | $423.80 M(-5.2%) |
| Mar 2016 | - | $12.00 M(-78.8%) | $447.20 M(-11.2%) |
| Dec 2015 | $503.60 M(+48.8%) | $56.50 M(-83.7%) | $503.60 M(+0.9%) |
| Sept 2015 | - | $347.60 M(+1017.7%) | $499.09 M(+100.1%) |
| June 2015 | - | $31.10 M(-54.5%) | $249.44 M(-17.0%) |
| Mar 2015 | - | $68.40 M(+31.6%) | $300.52 M(-11.2%) |
| Dec 2014 | $338.50 M(-214.8%) | $51.99 M(-46.9%) | $338.50 M(+160.1%) |
| Sept 2014 | - | $97.95 M(+19.2%) | $130.15 M(-190.6%) |
| June 2014 | - | $82.18 M(-22.7%) | -$143.62 M(-27.9%) |
| Mar 2014 | - | $106.38 M(-168.0%) | -$199.23 M(-32.5%) |
| Dec 2013 | -$294.97 M(+80.6%) | -$156.35 M(-11.1%) | -$294.97 M(-2.8%) |
| Sept 2013 | - | -$175.82 M(-761.8%) | -$303.32 M(+279.7%) |
| June 2013 | - | $26.57 M(+149.8%) | -$79.88 M(-25.2%) |
| Mar 2013 | - | $10.63 M(-106.5%) | -$106.74 M(-34.7%) |
| Dec 2012 | -$163.36 M(+34.6%) | -$164.70 M(-445.9%) | -$163.36 M(-1032.9%) |
| Sept 2012 | - | $47.61 M(<-9900.0%) | $17.51 M(-119.9%) |
| June 2012 | - | -$287.00 K(-99.4%) | -$88.06 M(-33.3%) |
| Mar 2012 | - | -$45.99 M(-384.3%) | -$131.99 M(+8.8%) |
| Dec 2011 | -$121.33 M | $16.18 M(-127.9%) | -$121.33 M(-39.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$57.96 M(+31.1%) | -$200.82 M(-39.9%) |
| June 2011 | - | -$44.21 M(+25.1%) | -$333.94 M(+32.1%) |
| Mar 2011 | - | -$35.34 M(-44.2%) | -$252.80 M(+20.8%) |
| Dec 2010 | -$209.24 M(+28.7%) | -$63.31 M(-66.9%) | -$209.24 M(-2.2%) |
| Sept 2010 | - | -$191.08 M(-617.4%) | -$213.96 M(+278.8%) |
| June 2010 | - | $36.93 M(+348.9%) | -$56.48 M(-52.5%) |
| Mar 2010 | - | $8.23 M(-112.1%) | -$118.82 M(-26.9%) |
| Dec 2009 | -$162.62 M(-5.7%) | -$68.03 M(+102.5%) | -$162.62 M(+59.9%) |
| Sept 2009 | - | -$33.60 M(+32.2%) | -$101.72 M(-18.9%) |
| June 2009 | - | -$25.42 M(-28.5%) | -$125.39 M(-36.8%) |
| Mar 2009 | - | -$35.57 M(+398.9%) | -$198.52 M(+15.1%) |
| Dec 2008 | -$172.48 M(+694.6%) | -$7.13 M(-87.6%) | -$172.48 M(+18.6%) |
| Sept 2008 | - | -$57.28 M(-41.9%) | -$145.46 M(+8.3%) |
| June 2008 | - | -$98.54 M(+934.0%) | -$134.34 M(+164.2%) |
| Mar 2008 | - | -$9.53 M(-147.9%) | -$50.84 M(+134.2%) |
| Dec 2007 | -$21.71 M(-78.6%) | $19.89 M(-143.1%) | -$21.71 M(-77.7%) |
| Sept 2007 | - | -$46.16 M(+206.9%) | -$97.19 M(+74.0%) |
| June 2007 | - | -$15.04 M(-176.7%) | -$55.85 M(-30.6%) |
| Mar 2007 | - | $19.61 M(-135.3%) | -$80.45 M(-20.8%) |
| Dec 2006 | -$101.63 M(+43.7%) | -$55.60 M(+1052.7%) | -$101.63 M(+73.1%) |
| Sept 2006 | - | -$4.82 M(-87.8%) | -$58.71 M(-1.6%) |
| June 2006 | - | -$39.63 M(+2416.5%) | -$59.66 M(-8.1%) |
| Mar 2006 | - | -$1.57 M(-87.6%) | -$64.93 M(-8.2%) |
| Dec 2005 | -$70.74 M(+449.7%) | -$12.68 M(+119.6%) | -$70.74 M(+4.8%) |
| Sept 2005 | - | -$5.77 M(-87.1%) | -$67.48 M(+8.0%) |
| June 2005 | - | -$44.90 M(+507.9%) | -$62.50 M(+212.8%) |
| Mar 2005 | - | -$7.39 M(-21.6%) | -$19.98 M(+55.2%) |
| Dec 2004 | -$12.87 M(-72.9%) | -$9.42 M(+1089.1%) | -$12.87 M(+48.6%) |
| Sept 2004 | - | -$792.00 K(-66.8%) | -$8.66 M(-52.0%) |
| June 2004 | - | -$2.38 M(+760.3%) | -$18.05 M(+7.3%) |
| Mar 2004 | - | -$277.00 K(-94.7%) | -$16.83 M(-64.6%) |
| Dec 2003 | -$47.54 M(-139.5%) | -$5.21 M(-48.8%) | -$47.54 M(-11.6%) |
| Sept 2003 | - | -$10.18 M(+776.2%) | -$53.77 M(-166.2%) |
| June 2003 | - | -$1.16 M(-96.2%) | $81.18 M(-3.9%) |
| Mar 2003 | - | -$30.98 M(+170.7%) | $84.48 M(-29.8%) |
| Dec 2002 | $120.36 M(-189.3%) | -$11.45 M(-109.2%) | $120.36 M(+56.1%) |
| Sept 2002 | - | $124.78 M(+5744.3%) | $77.10 M(-168.7%) |
| June 2002 | - | $2.13 M(-56.4%) | -$112.15 M(-8.0%) |
| Mar 2002 | - | $4.89 M(-108.9%) | -$121.96 M(-9.5%) |
| Dec 2001 | -$134.78 M(-1983.2%) | -$54.71 M(-15.2%) | -$134.78 M(+50.9%) |
| Sept 2001 | - | -$64.48 M(+740.4%) | -$89.31 M(+258.7%) |
| June 2001 | - | -$7.67 M(-3.2%) | -$24.89 M(+43.3%) |
| Mar 2001 | - | -$7.93 M(-14.1%) | -$17.38 M(-342.8%) |
| Dec 2000 | $7.16 M(-129.7%) | -$9.23 M(>+9900.0%) | $7.16 M(-80.7%) |
| Sept 2000 | - | -$65.00 K(-58.2%) | $37.09 M(+4.6%) |
| June 2000 | - | -$155.60 K(-100.9%) | $35.45 M(-303.8%) |
| Mar 2000 | - | $16.61 M(-19.8%) | -$17.39 M(-27.8%) |
| Dec 1999 | -$24.10 M(+109.6%) | $20.70 M(-1317.6%) | -$24.10 M(-46.2%) |
| Sept 1999 | - | -$1.70 M(-96.8%) | -$44.80 M(+3.9%) |
| June 1999 | - | -$53.00 M(-635.4%) | -$43.10 M(-535.4%) |
| Mar 1999 | - | $9.90 M | $9.90 M |
| Dec 1998 | -$11.50 M | - | - |
FAQ
- What is United Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for United Therapeutics?
- What is United Therapeutics annual CFI year-on-year change?
- What is United Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for United Therapeutics?
- What is United Therapeutics quarterly CFI year-on-year change?
- What is United Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for United Therapeutics?
- What is United Therapeutics TTM CFI year-on-year change?
What is United Therapeutics annual cash flow from investing activities?
The current annual CFI of UTHR is -$719.60 M
What is the all time high annual CFI for United Therapeutics?
United Therapeutics all-time high annual cash flow from investing activities is $503.60 M
What is United Therapeutics annual CFI year-on-year change?
Over the past year, UTHR annual cash flow from investing activities has changed by +$91.90 M (+11.32%)
What is United Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of UTHR is -$114.90 M
What is the all time high quarterly CFI for United Therapeutics?
United Therapeutics all-time high quarterly cash flow from investing activities is $735.30 M
What is United Therapeutics quarterly CFI year-on-year change?
Over the past year, UTHR quarterly cash flow from investing activities has changed by +$198.50 M (+63.34%)
What is United Therapeutics TTM cash flow from investing activities?
The current TTM CFI of UTHR is $582.50 M
What is the all time high TTM CFI for United Therapeutics?
United Therapeutics all-time high TTM cash flow from investing activities is $582.50 M
What is United Therapeutics TTM CFI year-on-year change?
Over the past year, UTHR TTM cash flow from investing activities has changed by +$1.53 B (+161.25%)